Founded by Dr Mark Lightowler, Phorix brings 30 years of pharmaceutical and healthcare science, strategy and branding, combined with behavioural science and engagement practice. Lightowler takes on the role of executive director of engagement, science and strategy at mccglc, strengthening the agency’s capabilities in life sciences, healthcare and technology sectors.
He brings a wealth of experience and is widely sought as a commentator and speaker, as well as holding numerous academic positions including visiting senior lecturer at King’s College London school of Cancer and Pharmaceutical sciences, chairman of digital medicines module at GMDP Academy.
